Why Life Science organisations should be digitising data capture processes
In the Life Sciences industry, companies are faced with several regulatory requirements, meaning they must have the appropriate labels at all times to ensure they do not face a loss of revenue, recall of supplies or fines.
A NiceLabel survey revealed that 78% of pharma and biopharma companies don’t have a modern, digital labelling solution in place and 83% are looking for a new system that can reduce manual tasks and increase accuracy.
As well as reducing manual tasks and increasing accuracy, by digitalising data capture process in your company, you can benefit in a number of ways – a major one being for better GMP compliance.
GMP (Good Manufacturing Practice) is a practice used to ensure products produced are of a consistent standard and are controlled to meet quality standards within manufacturing companies. It is in place in the life sciences industry in order to minimize any risks involved in production that cant be eliminated when testing the final product.
GMP enforces the need for high quality and globally recognisable products. Companies should be using solutions that will meet GMP compliance in order to adhere global standards. Keeping up with this level of compliance can be difficult, especially when time consuming manual processes are involved. To reduce this burden, organisations need a solutions which meets GMP standards and is easily implemented into daily tasks.
A well as GMP, for global companies there are also local regulations that must be adhered to, meaning companies must be in compliance with multiple label rules for different countries, meaning the risks of products being mislabelled are higher. In addition to this, there are newer labels being introduces such as QR codes and RFID tags that have to be taken into account in the labelling process.
Given these factors, a solution that will automate and set a standard for labelling processes is essential for organisations struggling to manage the various aspects of labelling compliance.
Why labelling matters
In 2018, 9% of all medical device recall events – and the return of over a million units – were due to labelling issues, with printing errors undoubtedly a factor. It only takes one stray label, instructions for use (IFU) or printing error to cause a product recall. A trivial issue like a faulty print ribbon, for example, can lead to missing, unreadable or misinterpreted content.
This makes the labelling process essential in maintaining compliance. Not only do labels act as unique identifiers to show product authenticity, but they also ensure ingredients are understood. Because of this, there is no room for error as the consequences of any inaccurate ingredients are too much.
With VisionID’s digital data capture solutions for life sciences, companies can better monitor GMP compliance and track any errors simply. They will also be in a better position to address new regulatory changes and advance in other areas such as innovation for new products and treatments with usual time consuming manual processes being eliminated.
VisionID are experts in
- Sterile services labelling including autoclave
- Capital asset labelling and tracking
- Rating plate and component labelling
- Shelf or scan-pallet labels
- Water-immersed labels or labels which are continually scanned
- Applications where labels are in contact with moving parts or friction conveyor drives
- Labels exposed to acid or alkali solutions; top side printed circuit board applications
Making efficient labelling technology a priority will help address inconsistent processes, reduce human errors, enhance quality of labels and more. This will in turn allow your company to produce high quality labels whilst saving time on trivial mistakes.
By optimising your manufacturing processes through automating data capture, you can mobilise your workforce and track your supply chain in real time with our solutions for Life Sciences.
Learn more about our life sciences solutions here.
Or find out more about our range of label printers here.